Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343052 · ClinicalTrials.gov registry record
Hamstring Injury (HAMIR) Index
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 699
- Enrollment target
NCT05343052: Completed study, sponsored by University of Wisconsin, Madison.
NCT05343052 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 699 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05343052 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 699 participants
- Enrollment target
Study Summary
The investigators will combine state-of-the-art quantitative imaging, on-field biomechanics, and computational analytics into the largest-of-its-kind study to assess hamstring strain injury (HSI) risk and recovery in elite collegiate football players. The study will take place over 3 years and enroll up to 560 student athletes from Division I (D1) teams: University of Wisconsin-Madison, Brigham Young University and the University of North Carolina-Chapel Hill.
Primary Outcome
The outcome will be occurrence of an index HSI, measured at the athlete level. Athlete characteristics will be used to develop the quantitative HAMIR index to predict those at greatest risk of HSI. This aim will also identify potential future targets for injury risk mitigation and prophylactic strategies. HSI defined as an acute injury to the posterior thigh that limits full, unrestricted sports participation and includes two or more of the following symptoms: palpable pain along the hamstring
Interventions
- OTHER Clinical Assessments
- OTHER Patient Reported Outcomes Surveys
- OTHER Biomechanical and Neuromuscular Assessments
- DEVICE Conventional MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 699 participants |
| Start Date | 2022-04-25 |
| Est. Completion | 2025-06-05 |
What the finished NCT05343052 record still lists
NCT05343052 is an observational study that tracks outcomes without assigning an intervention. The registered 699 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Clinical Assessments is the first listed.
NCT05343052 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05343052 about?
NCT05343052 is a clinical study titled "Hamstring Injury (HAMIR) Index". The investigators will combine state-of-the-art quantitative imaging, on-field biomechanics, and computational analytics into the largest-of-its-kind study to assess hamstring strain injury (HSI) risk and recovery in elite collegiate football players. The study will take place over 3 years and enrol...
What is the current status of trial NCT05343052?
This trial is currently completed. The enrollment target is 699 participants. The study started on 2022-04-25. Estimated completion is 2025-06-05.
What interventions are being tested in trial NCT05343052?
The interventions under investigation include: Clinical Assessments (OTHER), Patient Reported Outcomes Surveys (OTHER), Biomechanical and Neuromuscular Assessments (OTHER), Conventional MRI (DEVICE).
Who is sponsoring clinical trial NCT05343052?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07187115 · 699 participants · NA
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI